A csonttörés kockázatának megíté lése osteoporosisban

Translated title of the contribution: Evaluation of fracture risk in osteoporosis

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Osteoporotic fractures are associated with excess mortality. Effective treatment options are available, which reduce the risk of vertebral and non-vertebral fractures, but the identification of patients with high fracture risk is problematic. Low bone mineral density (BMD) - the basis for the diagnosis of osteoporosis - is an important, but not the only determinant of fracture risk. Several clinical risk factors are know that operate partially or completely independently of BMD, and affect the fracture risk. These include age, a prior fragility fracture, a parental history of hip fracture, use of corticosteroids, excess alcohol intake, rheumatoid arthritis, and different types of diseases which can cause secondary bone loss. The FRAX® tool integrates the weight of above mentioned clinical risk factors for fracture risk assessment with or without BMD value, and calculates the 10-year absolute risk of hip and major osteoporotic (hip, vertebral, humerus and forearm together) fracture probabilities. Although the use of data is not yet uniform, the FRAX® is a promising opportunity to identify individuals with high fracture risk. The accumulation of experience with FRAX® is going on and it can modify current diagnostic and therapeutic recommendations in Hungary as well.

Original languageHungarian
Pages (from-to)1304-1311
Number of pages8
JournalOrvosi Hetilap
Volume152
Issue number33
DOIs
Publication statusPublished - Aug 1 2011

Fingerprint

Osteoporosis
Bone Density
Hip
Osteoporotic Fractures
Hungary
Humerus
Hip Fractures
Forearm
Rheumatoid Arthritis
Adrenal Cortex Hormones
Alcohols
Weights and Measures
Bone and Bones
Mortality
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A csonttörés kockázatának megíté lése osteoporosisban. / Szathmári, Miklós.

In: Orvosi Hetilap, Vol. 152, No. 33, 01.08.2011, p. 1304-1311.

Research output: Contribution to journalArticle

@article{fb2345832097482dacaa86fbf10595ca,
title = "A csontt{\"o}r{\'e}s kock{\'a}zat{\'a}nak meg{\'i}t{\'e} l{\'e}se osteoporosisban",
abstract = "Osteoporotic fractures are associated with excess mortality. Effective treatment options are available, which reduce the risk of vertebral and non-vertebral fractures, but the identification of patients with high fracture risk is problematic. Low bone mineral density (BMD) - the basis for the diagnosis of osteoporosis - is an important, but not the only determinant of fracture risk. Several clinical risk factors are know that operate partially or completely independently of BMD, and affect the fracture risk. These include age, a prior fragility fracture, a parental history of hip fracture, use of corticosteroids, excess alcohol intake, rheumatoid arthritis, and different types of diseases which can cause secondary bone loss. The FRAX{\circledR} tool integrates the weight of above mentioned clinical risk factors for fracture risk assessment with or without BMD value, and calculates the 10-year absolute risk of hip and major osteoporotic (hip, vertebral, humerus and forearm together) fracture probabilities. Although the use of data is not yet uniform, the FRAX{\circledR} is a promising opportunity to identify individuals with high fracture risk. The accumulation of experience with FRAX{\circledR} is going on and it can modify current diagnostic and therapeutic recommendations in Hungary as well.",
keywords = "fracture risk, FRAX{\circledR} tool for evaluation of fracture risk, osteoporosis",
author = "Mikl{\'o}s Szathm{\'a}ri",
year = "2011",
month = "8",
day = "1",
doi = "10.1556/OH.2011.29191",
language = "Hungarian",
volume = "152",
pages = "1304--1311",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "33",

}

TY - JOUR

T1 - A csonttörés kockázatának megíté lése osteoporosisban

AU - Szathmári, Miklós

PY - 2011/8/1

Y1 - 2011/8/1

N2 - Osteoporotic fractures are associated with excess mortality. Effective treatment options are available, which reduce the risk of vertebral and non-vertebral fractures, but the identification of patients with high fracture risk is problematic. Low bone mineral density (BMD) - the basis for the diagnosis of osteoporosis - is an important, but not the only determinant of fracture risk. Several clinical risk factors are know that operate partially or completely independently of BMD, and affect the fracture risk. These include age, a prior fragility fracture, a parental history of hip fracture, use of corticosteroids, excess alcohol intake, rheumatoid arthritis, and different types of diseases which can cause secondary bone loss. The FRAX® tool integrates the weight of above mentioned clinical risk factors for fracture risk assessment with or without BMD value, and calculates the 10-year absolute risk of hip and major osteoporotic (hip, vertebral, humerus and forearm together) fracture probabilities. Although the use of data is not yet uniform, the FRAX® is a promising opportunity to identify individuals with high fracture risk. The accumulation of experience with FRAX® is going on and it can modify current diagnostic and therapeutic recommendations in Hungary as well.

AB - Osteoporotic fractures are associated with excess mortality. Effective treatment options are available, which reduce the risk of vertebral and non-vertebral fractures, but the identification of patients with high fracture risk is problematic. Low bone mineral density (BMD) - the basis for the diagnosis of osteoporosis - is an important, but not the only determinant of fracture risk. Several clinical risk factors are know that operate partially or completely independently of BMD, and affect the fracture risk. These include age, a prior fragility fracture, a parental history of hip fracture, use of corticosteroids, excess alcohol intake, rheumatoid arthritis, and different types of diseases which can cause secondary bone loss. The FRAX® tool integrates the weight of above mentioned clinical risk factors for fracture risk assessment with or without BMD value, and calculates the 10-year absolute risk of hip and major osteoporotic (hip, vertebral, humerus and forearm together) fracture probabilities. Although the use of data is not yet uniform, the FRAX® is a promising opportunity to identify individuals with high fracture risk. The accumulation of experience with FRAX® is going on and it can modify current diagnostic and therapeutic recommendations in Hungary as well.

KW - fracture risk

KW - FRAX® tool for evaluation of fracture risk

KW - osteoporosis

UR - http://www.scopus.com/inward/record.url?scp=80051738017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051738017&partnerID=8YFLogxK

U2 - 10.1556/OH.2011.29191

DO - 10.1556/OH.2011.29191

M3 - Article

C2 - 21824857

AN - SCOPUS:80051738017

VL - 152

SP - 1304

EP - 1311

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 33

ER -